APRINOIA Therapeutics has filed with the U.S. Securities and Exchange Commission to raise $50,000,000.00 in an Initial Public Offering
According to filings with the U.S. Securities and Exchange Commission, APRINOIA Therapeutics is raising $50,000,000.00 in new funding. About APRINOIA Therapeutics: Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that…